Fluctuating parkinsonism: A pilot study of single afternoon dose of levodopa methyl ester

Journal of Neurology

Volumn 243, Issue 5, 1996, Pages 377-380

  Stocchi, Fabrizio ^c,d   Barbato, Luca ^b   Bramante, Lucia ^a   Nordera, Giampietro ^b   Vacca, Laura ^c   Ruggieri, Stefano ^a  

^a Institute of Neurosciences   (Italy)

^b Istituto Antonio Benedetti   (Italy)

^c SAPIENZA UNIVERSITY OF ROME   (Italy)

^d Department of Neurosciences ^*  (Italy)

Author keywords

Levodopa; Levodopa methyl ester; Motor fluctuations; Parkinson's disease

Indexed keywords

ANTIPARKINSON AGENT; LEVODOPA METHYL ESTER;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; LATENT PERIOD; MALE; PARKINSONISM; PRIORITY JOURNAL; RATING SCALE; SELF EVALUATION;

ADMINISTRATION, ORAL; AGED; ANALYSIS OF VARIANCE; ANTIPARKINSON AGENTS; CIRCADIAN RHYTHM; DELAYED-ACTION PREPARATIONS; DOPAMINE AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EVALUATION STUDIES; FEMALE; HUMANS; INFUSIONS, PARENTERAL; LEVODOPA; MALE; MIDDLE AGED; PARKINSON DISEASE; PILOT PROJECTS;

EID: 0029882818     PISSN: 03405354     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF00868995     Document Type: Article

References (12)

1. Cooper DR, Marrel C, Testa B, et al (1984) L-dopa methyl ester: a candidate for chronic systemic delivery of L-dopa in parkinson's disease. Clin Neuropharmacol 7: 89-98
2. Hardie RJ, Lees AJ, Stern GM (1984) On-off fluctuations in Parkinson's disease: a clinical and a neuropharmacological study. Brain 107:487-506
3. Melamed E, Bitton V, Zelig O (1986) Delayed onset to responses to single doses of L-Dopa in Parkinsonian fluctuators on long term L-Dopa therapy. Clin Neuropharmacol 2: 182-188
4. Nutt JG, Woodward WR, Hammerstad JP, Carter JH, Anderson JL (1984) The on-off phenomenon in Parkinson's disease. N Engl J Med 310: 483-488
5. Pincus JH, Barry K (1987) Influence of dietary protein on motor fluctuations in Parkinson's disease. Arch Neurol 44: 1006-1009
6. Poewe WH, Lees AJ, Stern GM (1988) Dystonia in Parkinson's disease: clinical and pharmacological features. Ann Neurol 23: 73-78
7. Quinn NP, Lang AE, Koller WC, Marsden CD (1986) Painful Parkinson's disease. Lancet I: 1366-1369
8. Steiger MJ, Stocchi F, Carta A, et al (1991) The clinical efficacy of oral levodopa Methyl Ester solution in reversing afternoon 'Off' periods in Parkinson's disease. Clin Neuropharmacol 14: 241-244
9. Stocchi F, Ruggieri S, Carta A, Jenner P. Agnoli A (1989) Different therapeutic approaches to complicated Parkinson's disease. In: Quinn NP, Jenner PG (eds) Disorders of movement. Clinical, pharmacological and physiological aspects. Academic Press, London, pp 137-146
10. Stocchi F, Ruggieri S, Carta A, et al (1992) Intravenous boluses and continuous infusions of L-dopa methyl ester in fluctuating patients with Parkinson's disease. Mov Disord 7: 249-256
11. Stocchi F, Quinn NP, Barbato L, Patsalos P, Ruggieri S, Marsden CD (1994) Comparison between a prompt and slow release preparation of L-Dopa and a combination of the two: clinical and pharmacokinetic study. Clin Neuropharmacol 7: 89-98
12. Wade DN, Mearrick PT, Morris JL (1973) Active transport of L-dopa in the intestine. Nature 242: 463-465